Bigul

Sub.: Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we certify that M/s Alankit Assignments Limited, a Category-I Registrar and Share Transfer Agent, registered with the Securities and Exchange Board of India vide Registration No.: INR000002532, is the Registrar and Share Transfer Agent (the 'RTA') of Jubilant Life Sciences Limited (the 'Company') and all activities...
15-10-2018
Bigul

Sub.: Schedule Of Investor Conference Call For Jubilant Life Sciences Limited - Unaudited Financial Results For The Quarter Ended September 30, 2018

Sub.: Schedule of Investor Conference Call for Jubilant Life Sciences Limited - Unaudited Financial Results for the quarter ended September 30, 2018 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company is organising a Conference Call on October 22, 2018 after submission of the financial results for the quarter ended...
15-10-2018
Bigul

Board Meeting Intimation for Sub: Intimation Of Board Meeting - October 22, 2018

JUBILANT LIFE SCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2018 ,inter alia, to consider and approve In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday,...
15-10-2018
Bigul

Statement Of Investor Complaints For The Quarter Ended September 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0550 Name of the Signatory :- Rajiv ShahDesignation :- Company Secretary and Compliance Officer
12-10-2018
Bigul

Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Jubilant Life Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
28-09-2018
Bigul

Annual Report Of Jubilant Life Sciences Limited- FY 2017-18

We enclose Annual report of Jubilant Life Sciences Limited for the Financial Year 2017-18
27-09-2018
Bigul

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

This is further to our letter dated September 26, 2018. Pursuant to the provisions of Regulation 44 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose details of the voting results (for e-Voting and Poll) in respect of the 40th Annual General Meeting of the shareholders of Jubilant Life Sciences Limited held on Wednesday,...
27-09-2018
Bigul

Shareholder Meeting / Postal Ballot-Outcome of AGM

Sub: Proceedings of 40th Annual General Meeting of Jubilant Life Sciences Limited Dear Sirs, The 40th Annual General Meeting ('AGM') of Jubilant Life Sciences Limited ('the Company') has been held today i.e. Wednesday, September 26, 2018 at 11.30 a.m. at the Registered Office of the Company at Bhartiagram, Gajraula, District Amroha - 244 223, Uttar Pradesh, India....
26-09-2018
Bigul

Intimation Of Schedule Of Analyst / Institutional Investors Meeting By Our Wholly-Owned Subsidiary, Jubilant Pharma Limited

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform you that our material wholly-owned subsidiary, Jubilant Pharma Limited (a company incorporated under the laws of Singapore) ('JPL') proposes to organise exploratory meetings with one or more international institutional investors located in different jurisdictions, between September...
24-09-2018
Bigul

Closure of Trading Window

Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from Saturday, September 22, 2018 and the same shall remain closed till 48 hours after the announcement of the financial results for the quarter ending September 30, 2018 to the Stock Exchanges....
21-09-2018
Next Page
Close

Let's Open Free Demat Account